Intracavitary rifampicin.
dc.contributor.author | Purohit, S D | en_US |
dc.contributor.author | Gupta, P R | en_US |
dc.contributor.author | Koolwal, S | en_US |
dc.contributor.author | Jain, B L | en_US |
dc.contributor.author | Mehta, Y R | en_US |
dc.date.accessioned | 1985-08-01 | en_US |
dc.date.accessioned | 2009-05-31T04:25:39Z | |
dc.date.available | 1985-08-01 | en_US |
dc.date.available | 2009-05-31T04:25:39Z | |
dc.date.issued | 1985-08-01 | en_US |
dc.identifier.citation | Purohit SD, Gupta PR, Koolwal S, Jain BL, Mehta YR. Intracavitary rifampicin. Journal of the Association of Physicians of India. 1985 Aug; 33(8): 556 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/94742 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.japi.org | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Rifampin --administration & dosage | en_US |
dc.subject.mesh | Tuberculosis, Pulmonary --drug therapy | en_US |
dc.title | Intracavitary rifampicin. | en_US |
dc.type | Comparative Study | en_US |
dc.type | Letter | en_US |
Files
License bundle
1 - 1 of 1